Boosting Cancer Immunotherapy via Reversing PD-L1–Mediated Immunosuppression with a Molecularly Imprinted Lysosomal Nanodegrader
ACS Nano · 2024
DOI: 10.1021/acsnano.4c07416 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, 2024. Verfasst von Haifeng Lu und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering, Nanjing University, 163 Xianlin Avenue, …. Hauptthemen laut MEDLINE: B7-H1 Antigen, Lysosomes, Immunotherapy, Molecular Imprinting. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Key Programme, Anhui Provincial Department of Education, Nanjing University.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering, Nanjing University, 163 Xianlin Avenue, Nanjing 210023, China.
ORCID-Profile: Zhen Liu
Förderung
- Key Programme
- Anhui Provincial Department of Education
- Nanjing University
- Excellent Young Scientists Fund
Zitieren
APA
Lu, H., Guan, P., Xu, S., Han, Y., & Liu, Z. (2024). Boosting Cancer Immunotherapy via Reversing PD-L1–Mediated Immunosuppression with a Molecularly Imprinted Lysosomal Nanodegrader. ACS Nano. https://doi.org/10.1021/acsnano.4c07416
Vancouver
Lu H, Guan P, Xu S, Han Y, Liu Z. Boosting Cancer Immunotherapy via Reversing PD-L1–Mediated Immunosuppression with a Molecularly Imprinted Lysosomal Nanodegrader. ACS Nano. 2024. doi:10.1021/acsnano.4c07416
BibTeX
@article{Lu2024,
author = {Lu, Haifeng and Guan, Peixin and Xu, Shuxin and Han, Yanjie and Liu, Zhen},
title = {Boosting Cancer Immunotherapy via Reversing PD-L1–Mediated Immunosuppression with a Molecularly Imprinted Lysosomal Nanodegrader},
journal = {ACS Nano},
year = {2024},
doi = {10.1021/acsnano.4c07416}
}
EUVIMED